Pharmacokinetics variability: Why nanoparticles are not just magic-bullets in oncology.

Rodallec, Anne; Benzekry, Sebastien; Lacarelle, Bruno; Ciccolini, Joseph; Fanciullino, Raphaelle

Rodallec, Anne; Benzekry, Sebastien; Lacarelle, Bruno; Ciccolini, Joseph; Fanciullino, Raphaelle.

Affiliation

Rodallec A; SMARTc unit, Center for Research on Cancer of Marseille (CRCM): UMR Inserm 1068, CNRS UMR 7258, Aix Marseille Université, Marseille, France.
Benzekry S; MONC Team, INRIA, Bordeaux, France.
Lacarelle B; SMARTc unit, Center for Research on Cancer of Marseille (CRCM): UMR Inserm 1068, CNRS UMR 7258, Aix Marseille Université, Marseille, France.
Ciccolini J; SMARTc unit, Center for Research on Cancer of Marseille (CRCM): UMR Inserm 1068, CNRS UMR 7258, Aix Marseille Université, Marseille, France.
Fanciullino R; SMARTc unit, Center for Research on Cancer of Marseille (CRCM): UMR Inserm 1068, CNRS UMR 7258, Aix Marseille Université, Marseille, France. Electronic address: raphaelle.fanciullino@univ-amu.fr.

Crit Rev Oncol Hematol ; 129: 1-12, 2018 Sep.

Article in En | MEDLINE | ID: mdl-30097227

Subject(s)

Antineoplastic Agents/administration & dosage; Drug Delivery Systems; Nanoparticles/administration & dosage; Neoplasms/drug therapy; Antineoplastic Agents/chemistry; Drug Carriers; Humans; Models, Biological; Nanoparticles/chemistry; Treatment Outcome

Key words

Liposomes; MPS; Modeling; Nanoparticles; Oncology; Pharmacokinetics; Variability

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Drug Delivery Systems / Nanoparticles / Neoplasms / Antineoplastic Agents Type of study: Prognostic_studies Limits: Humans Language: En Journal: Crit Rev Oncol Hematol Journal subject: HEMATOLOGIA / NEOPLASIAS Year: 2018 Document type: Article Affiliation country: France Country of publication: Netherlands

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google